PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10169268

Exceptional CHF program is built on best practices, benchmarks.

View original source ↗Export metadata ↓

Abstract

Advocate Health Care in Oak Brook, IL, has built an exceptionally successful congestive heart failure (CHF) program based on best practices. Advocate's 90-day readmission rate for CHF patients is half the national average. A new part of the program, transitional care, has a readmission rate of just 4%. It is based on telephone follow-up and ongoing patient education. Advocate managers are building an internal database for their program, which will allow emergency department staff to access patients' latest labs, EKGs, blood serums, and other information.

Explore related subjects

AftercareCommunity NetworksContinuity of Patient CareCritical PathwaysEfficiency, OrganizationalHeart FailureHome Care ServicesHumansIllinoisPatient ReadmissionJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

1997. Exceptional CHF program is built on best practices, benchmarks.. https://pubmed.ncbi.nlm.nih.gov/10169268/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

Decision-analytic model and cost-effectiveness evaluation of postmastectomy radiation therapy in high-risk premenopausal breast cancer patients.

PURPOSE: To present a decision model that describes the clinical and economic outcomes of node-positive breast cancer with and without postmastectomy radiation therapy (PMRT). METHODS: A Markov process was constructed to project the natural history of breast cancer following mastectomy in premenopausal node-positive women. Biannual hazards of local and distant recurrence without PMRT were derived from a large meta-analysis of adjuvant systemic therapy trials for breast cancer. The addition of PMRT reduced the risk of disease relapse by an odds ratio of 0.69. Costs of PMRT ($11,600) and recurrent breast cancer ($4,250 to 16,200/year) were estimated from available literature. The model projected number of recurrences, relapse-free and overall survival, and costs to 15 years, using a discount rate of 3%. Cost-effectiveness ratios were calculated per incremental year of life and quality-adjusted year of life gained. One- and two-way sensitivity analyses were performed to determine the sensitivity of results to clinical and economic assumptions. RESULTS: The model projected 15-year relapse-free survival of 52% and 43% with and without PMRT, respectively. Overall survival was increased from 48% to 55% with PMRT, resulting in an incremental 0.29 years of life gained per subject. PMRT increased 15-year costs from $40,800 to $48,100. Cost per year of life gained was $24,900, or $22,600 when survival was adjusted for quality of life. Results of the model were relatively sensitive to radiation therapy cost and breast cancer relapse risk. CONCLUSION: This analysis suggests that PMRT offers substantial clinical benefits achieved in a cost-effective manner, with an average cost per year of life gained of $24,900. Results of the model were robust under a wide range of clinical and economic parameters.

Aftercare↗
PubMed2002

Neonatal cleft lip and cleft palate repair.

Facial clefting is one of the most common birth defects and having a child born with this defect can be a devastating experience for parents and family members. Until recently, repair of cleft lip and palate deformities was deferred until the infant had reached 10 weeks of age, 10 pounds in weight, and a hemoglobin level of 10 gm per 100 mL. This criteria eliminated neonates 28 days of age or younger from the possibility of early repair. Waiting until these criteria were achieved often caused problems with parent-infant bonding and infant growth and development. Advances in neonatology and pediatric anesthesia now have made it possible to perform cleft surgery during the neonatal period. This article discusses the anatomy and embryology of cleft deformities and how cleft repair surgery now can be performed on the neonate.

Aftercare↗